InvestorsHub Logo
Followers 68
Posts 5584
Boards Moderated 0
Alias Born 01/13/2012

Re: A deleted message

Wednesday, 06/06/2012 12:40:48 PM

Wednesday, June 06, 2012 12:40:48 PM

Post# of 331192
I'm with you Rich - there is a smell in the air. Paul and Robert are going at each other and beyond a number of lines of dignified discussion and debate.

To Paul and Robert, the accusations you are making are are flying in the face of logic and litigation is just around the corner. There is lots of libel here to keep lawyers busy for a while. Meanwhile, no one really cares much about he said/she said issues, but we do care about:

- How BIEL is doing opposite the FDA;
- How is the FDA going to retract and reverse the decision statements, that BIEL, I assume its legal counsel, and posters here say are erroneous and approve ALLAY, while saving face at the same time?;
- How is the ActiPatch application going at FDA?; and
- What progress, if any, has been made with making a deal with a retail chain of pharmacies in Canada, Shoppers Drug Mart, Katz Group (Rexall, IDA etc) and the Jean Coutu chain and all the other countries where BIEL's product line has achieved approval?

Just did a little reading. Shoppers Drug Mart, Pharmacie Jean Coutu and the Katz Group operate approx. 3,500 drugstores in Canada and the US, doing approx. $18Billion(CAD$). By comparison, Walgreens operates 8,300 drugstores and does $72Billion(US$). The US is generally considered to be 10 times Canada in many categories. Therefor, if I'm the CEO of BIEL, is Canada not my number one priority and focus and wouldn't I love to do a deal with those 3 drugstore chains? All of them? While my legal counsel, Senator Barbara Mikulski and the Inspector General figure a way for the FDA to save face? Make a deal BIEL.